The Future of MRI in Prostate Cancer

Andrew Vickers, PhD
Published: Thursday, Jul 27, 2017



Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the future of MRI in prostate cancer.

Vickers says that steps should be taken to improve MRI so that it can be a tool that provides a high and consistent negative predictive value.

Another idea being discussed in the space is risk stratification prior to MRI, Vickers adds.
 


Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the future of MRI in prostate cancer.

Vickers says that steps should be taken to improve MRI so that it can be a tool that provides a high and consistent negative predictive value.

Another idea being discussed in the space is risk stratification prior to MRI, Vickers adds.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Oncology Briefings™: Current Perspectives on Preventing and Managing Tumor Lysis SyndromeJun 30, 20191.0
Publication Bottom Border
Border Publication
x